EORI keeps an eye on changes in the fields of Open Science, FAIR data principles, and others, and directs any interested parties to important updates:
- Of significance, the European Research Council has banned grant applicants from including journal metrics when applying for grants (here). This is a welcome step forward for research being considered based on quality rather than where it’s been published. Hopefully we’ll see more of this from other funders.
- Clinical trial data from many FDA-approved drugs are still not available (here); for 3/4 products, one or more relevant trial(s) are unavailable for independent inspection. Further, around 1/4 of these breached legal requirements. There are suggestions that the introduction of European-style legislation could help remedy this (here), and allow for relevant data to be accessible.
- This systematic review and meta-analysis of attempts to improve the peer review process of biomedical research. It neatly synthesises the results of various interventions, and may give us an idea of how the peer review process may change for the better in the future.